For adults in Washington researching weight management options, Tirzepatide is the active pharmaceutical ingredient in the FDA-approved products Mounjaro / Zepbound, which were studied in trials supporting their FDA approvals. With District of Columbia reporting an obesity rate of 24.7% and diabetes affecting 8.5% of the population, demand for medically supervised GLP-1 care in the Southeast continues to grow. Weight Method's separate program prescribes compounded Tirzepatide (dispensed by U.S.-licensed 503A pharmacies and not FDA-approved) to Washington residents through telehealth — no clinic visit required.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Washington is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Washington, DC. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide works by mimicking incretin hormones that your body naturally produces after eating. It activates receptors in the brain that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. For Washington residents, Weight Method makes its compounded Tirzepatide program accessible through telehealth — a virtual consultation with a licensed provider, your prescription shipped to your door, and ongoing clinical support. Individual response varies, and your provider sets expectations based on your clinical profile rather than on brand-product trial figures.
In a fast-moving city like Washington, time is the scarcest resource. Tirzepatide requires just one weekly injection and periodic virtual check-ins with your Weight Method provider — no recurring clinic visits, no disruption to your routine. Your medication arrives at your Washington address, and clinical trials show 20-25% of body weight average weight loss, giving urban professionals a realistic path to results.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in District of Columbia and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.